bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)

C88H76Cl10F14N17O20P — CID 159415598

IUPACbis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCNC(=O)c1ccc(-c2nccnc2C2CN(C(=O)OC(C)(C)C)C2)cc1F.CNC(=O)c1ccc(-c2nccnc2C2CNC2)cc1F.Clc1ccc2cnc(Cl)nc2c1.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1CO.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=P(Cl)(Cl)Cl.O=c1ncc2ccc(Cl)cc2[nH]1.O=c1ncc2ccc(Cl)cc2[nH]1
InChIInChI=1S/C20H23FN4O3.C15H15FN4O.C8H4Cl2N2.2C8H5ClN2O.2C7H6ClNO2.C7H8ClNO.4C2HF3O2.Cl3OP/c1-20(2,3)28-19(27)25-10-13(11-25)17-16(23-7-8-24-17)12-5-6-14(15(21)9-12)18(26)22-4;1-17-15(21)11-3-2-9(6-12(11)16)13-14(10-7-18-8-10)20-5-4-19-13;9-6-2-1-5-4-11-8(10)12-7(5)3-6;2*9-6-2-1-5-4-10-8(12)11-7(5)3-6;2*8-4-1-2-5(7(10)11)6(9)3-4;8-6-2-1-5(4-10)7(9)3-6;4*3-2(4,5)1(6)7;1-5(2,3)4/h5-9,13H,10-11H2,1-4H3,(H,22,26);2-6,10,18H,7-8H2,1H3,(H,17,21);1-4H;2*1-4H,(H,10,11,12);2*1-3H,9H2,(H,10,11);1-3,10H,4,9H2;4*(H,6,7);
InChIKeyGRRJIQCHUXMNRY-UHFFFAOYSA-N
MW2343.15 g/mol
LogP20.39
Rot. Bonds9

About bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)

bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 159415598) has the molecular formula C88H76Cl10F14N17O20P and a molecular weight of 2343.15 g/mol. Its IUPAC name is bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Namebis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID159415598
Molecular FormulaC88H76Cl10F14N17O20P
Molecular Weight2343.15 g/mol
Exact Mass2337.19
IUPAC Namebis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCNC(=O)c1ccc(-c2nccnc2C2CN(C(=O)OC(C)(C)C)C2)cc1F.CNC(=O)c1ccc(-c2nccnc2C2CNC2)cc1F.Clc1ccc2cnc(Cl)nc2c1.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1CO.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=P(Cl)(Cl)Cl.O=c1ncc2ccc(Cl)cc2[nH]1.O=c1ncc2ccc(Cl)cc2[nH]1
InChIInChI=1S/C20H23FN4O3.C15H15FN4O.C8H4Cl2N2.2C8H5ClN2O.2C7H6ClNO2.C7H8ClNO.4C2HF3O2.Cl3OP/c1-20(2,3)28-19(27)25-10-13(11-25)17-16(23-7-8-24-17)12-5-6-14(15(21)9-12)18(26)22-4;1-17-15(21)11-3-2-9(6-12(11)16)13-14(10-7-18-8-10)20-5-4-19-13;9-6-2-1-5-4-11-8(10)12-7(5)3-6;2*9-6-2-1-5-4-10-8(12)11-7(5)3-6;2*8-4-1-2-5(7(10)11)6(9)3-4;8-6-2-1-5(4-10)7(9)3-6;4*3-2(4,5)1(6)7;1-5(2,3)4/h5-9,13H,10-11H2,1-4H3,(H,22,26);2-6,10,18H,7-8H2,1H3,(H,17,21);1-4H;2*1-4H,(H,10,11,12);2*1-3H,9H2,(H,10,11);1-3,10H,4,9H2;4*(H,6,7);
InChIKeyGRRJIQCHUXMNRY-UHFFFAOYSA-N
XLogP20.39
TPSA607.77 Ų
H-Bond Donors15
H-Bond Acceptors26
Rotatable Bonds9
Heavy Atoms150
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002343.15
LogP ≤ 520.39
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) (CID 159415598) is bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) is CNC(=O)c1ccc(-c2nccnc2C2CN(C(=O)OC(C)(C)C)C2)cc1F.CNC(=O)c1ccc(-c2nccnc2C2CNC2)cc1F.Clc1ccc2cnc(Cl)nc2c1.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1C(=O)O.Nc1cc(Cl)ccc1CO.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=P(Cl)(Cl)Cl.O=c1ncc2ccc(Cl)cc2[nH]1.O=c1ncc2ccc(Cl)cc2[nH]1.
What is the InChIKey of bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is GRRJIQCHUXMNRY-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23FN4O3.C15H15FN4O.C8H4Cl2N2.2C8H5ClN2O.2C7H6ClNO2.C7H8ClNO.4C2HF3O2.Cl3OP/c1-20(2,3)28-19(27)25-10-13(11-25)17-16(23-7-8-24-17)12-5-6-14(15(21)9-12)18(26)22-4;1-17-15(21)11-3-2-9(6-12(11)16)13-14(10-7-18-8-10)20-5-4-19-13;9-6-2-1-5-4-11-8(10)12-7(5)3-6;2*9-6-2-1-5-4-10-8(12)11-7(5)3-6;2*8-4-1-2-5(7(10)11)6(9)3-4;8-6-2-1-5(4-10)7(9)3-6;4*3-2(4,5)1(6)7;1-5(2,3)4/h5-9,13H,10-11H2,1-4H3,(H,22,26);2-6,10,18H,7-8H2,1H3,(H,17,21);1-4H;2*1-4H,(H,10,11,12);2*1-3H,9H2,(H,10,11);1-3,10H,4,9H2;4*(H,6,7);.
What are the key properties of bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid)?
bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 2343.15 g/mol, XLogP of 20.39, 9 rotatable bonds, 15 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for bis(2-amino-4-chlorobenzoic acid);(2-amino-4-chlorophenyl)methanol;4-[3-(azetidin-3-yl)pyrazin-2-yl]-2-fluoro-N-methylbenzamide;tert-butyl 3-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]pyrazin-2-yl]azetidine-1-carboxylate;bis(7-chloro-1H-quinazolin-2-one);2,7-dichloroquinazoline;phosphoryl trichloride;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 159415598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).